Cargando…
Glycoconjugate Vaccines for Prevention of Haemophilus influenzae Type b Diseases
This review summarizes the experience in laboratory- and industrial-scale syntheses of glycoconjugate vaccines used for prevention of infectious diseases caused by Haemophilus influenzae type b bacteria based on the linear capsular polysaccharide poly-3-β-D-ribosyl-(1→1)-D-ribitol-5-phosphate (PRP)...
Autores principales: | Khatuntseva, E. A., Nifantiev, N. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pleiades Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980804/ https://www.ncbi.nlm.nih.gov/pubmed/33776394 http://dx.doi.org/10.1134/S1068162021010106 |
Ejemplares similares
-
Synthesis of Pseudooligosaccharides Related to the Capsular Phosphoglycan of Haemophilus influenzae Type a
por: Kamneva, Anastasia A., et al.
Publicado: (2023) -
Simulating Immune Interference on the Effect of a Bivalent Glycoconjugate Vaccine against Haemophilus influenzae Serotypes “a” and “b”
por: Konini, Angjelina, et al.
Publicado: (2016) -
A glycoconjugate of Haemophilus influenzae Type b capsular polysaccharide with tetanus toxoid protein: hydrodynamic properties mainly influenced by the carbohydrate
por: Abdelhameed, Ali Saber, et al.
Publicado: (2016) -
Synthetic Analogs of Streptococcus pneumoniae Capsular Polysaccharides and Immunogenic Activities of Glycoconjugates
por: Gening, M. L., et al.
Publicado: (2021) -
Hib Vaccines: Their Impact on Haemophilus influenzae Type b Disease
por: Gilsdorf, Janet R
Publicado: (2021)